Perioperative use of tirofiban hydrochloride (Aggrastat) does not increase surgical bleeding after emergency or urgent coronary artery bypass grafting

Author:

Bizzarri Federico,Scolletta Sabino,Tucci Enrico,Lucidi Mara,Davoli Giuseppe,Toscano Thomas,Neri Eugenio,Muzzi Luigi,Frati Giacomo

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Pulmonary and Respiratory Medicine,Surgery

Reference14 articles.

1. Effects of platelet glycoprotein IIb/IIIa blockade with tirofiban on adverse cardiac events in patients with unstable angina or acute myocardial infarction undergoing coronary angioplasty;The RESTORE Study Group;Circulation,1997

2. Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q wave myocardial infarction;Prism-Plus Study Investigators;N Engl J Med,1998

3. Immediate coronary artery bypass surgery after platelet inhibition with eptifibatide: results from PURSUIT;Dyke;Ann Thorac Surg,2000

4. Inhibitors of the platelet receptor glycoprotein IIb/IIIa and complications during percutaneous coronary revascularization. Management strategies for the cardiac surgeon;Dyke;J Cardiovasc Surg,1999

5. Safety of glycoprotein IIb/ IIIa inhibitors: a heart surgeon's perspective;Dyke;Am Heart J,1999

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3